Analysis and Commentary STEVEN GROSSMAN 12/5/20 Analysis and Commentary STEVEN GROSSMAN 12/5/20 CDRH Update and Future Priorities Read More Advocacy at a Glance STEVEN GROSSMAN 9/1/17 Advocacy at a Glance STEVEN GROSSMAN 9/1/17 A "Breather", a Summary Review, and a Re-commitment Read More Advocacy at a Glance STEVEN GROSSMAN 2/24/17 Advocacy at a Glance STEVEN GROSSMAN 2/24/17 HHS Secretary Price Tours FDA and more Read More Advocacy at a Glance STEVEN GROSSMAN 4/1/16 Advocacy at a Glance STEVEN GROSSMAN 4/1/16 FDA’s Generics Performance Report and more Read More
Analysis and Commentary STEVEN GROSSMAN 12/5/20 Analysis and Commentary STEVEN GROSSMAN 12/5/20 CDRH Update and Future Priorities Read More
Advocacy at a Glance STEVEN GROSSMAN 9/1/17 Advocacy at a Glance STEVEN GROSSMAN 9/1/17 A "Breather", a Summary Review, and a Re-commitment Read More
Advocacy at a Glance STEVEN GROSSMAN 2/24/17 Advocacy at a Glance STEVEN GROSSMAN 2/24/17 HHS Secretary Price Tours FDA and more Read More
Advocacy at a Glance STEVEN GROSSMAN 4/1/16 Advocacy at a Glance STEVEN GROSSMAN 4/1/16 FDA’s Generics Performance Report and more Read More
